Skip to main content

Ampio Pharmaceuticals, Inc.

AMPEDelisted Apr 4, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001411906

Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Ampio Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of AMPE: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders34236+4
Shares411.1K291543.7K+132.9K (+32.3%)
Value$90.8K$65$124.7K+$34.0K (+37.5%)

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to AMPE in Q1 2023
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC17,200$4.00K0.00%
Two Sigma Securities, LLC13,885$3.23K0.00%
Goldman Sachs Group Inc12,921$3.01K0.00%
Virtu Financial LLC14,974$3.00K0.00%
Sunbelt Securities, Inc.1,518$3680.00%
Wells Fargo & Company764$1780.00%
WealthPLAN Partners, LLC167$390.00%

Sold out (3)

Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of AMPE in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Susquehanna International Group, LLP66,606$15.0K
StoneX Group Inc.20,109$4.53K
The PNC Financial Services Group, Inc.14$4

Not filed for Q1 2023 yet (2)

Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMPE in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Sanctuary Wealth Management, L.L.C.268$60
Trustcore Financial Services, LLC23$5